Vaccine Development

Feb 15, 2018
By BioPharm International Editors
Fluarix Tetra has been approved for use in children aged six months and above.
Jan 12, 2018
By BioPharm International Editors
An antibody-based Zika virus therapeutic that protected monkeys from infection might be safe enough for administration to pregnant women.
Jan 04, 2018
By BioPharm International Editors
The companies will collaborate on the development of vaccines to expand GeoVax’s cancer immunotherapy program.
Dec 14, 2017
By BioPharm International Editors
Children with a rare brainstem-based cancer might be helped by a new immunotherapy that targets a mutated protein found exclusively in cancer cells.
Nov 15, 2017
BioPharm International
The use of approved platform technologies can reduce the time and cost required to generate new vaccines.
Nov 15, 2017
BioPharm International
Despite the challenges and high cost of development, vaccine innovation is at an all-time high, as new approaches aim to improve global access.
Nov 15, 2017
BioPharm International
Alternatives to time-consuming, error-prone operations promise to reduce vaccine manufacturing costs and improve facility flexibility.
Nov 15, 2017
BioPharm International
Challenge trials may increase in coming years as new and improved challenge agents better emulate “natural” disease states.
Nov 15, 2017
BioPharm International
This article explores some of the challenges, services, and technologies that go into ensuring that vaccines are properly temperature controlled and maintain product integrity for delivery to patients.
Nov 15, 2017
BioPharm International
The use of therapeutic vaccines presents a new way to manage diseases, such as cancer and sexually transmitted diseases.
native1_300x100
lorem ipsum